# LDN for weight loss: what the trials measured

Source: https://pepvault.app/guides/ldn-for-weight-loss

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# Low-dose naltrexone (LDN) for weight loss: what the trials measured

Reviewed November 2026 20 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Does low-dose naltrexone cause weight loss? The human naltrexone weight trials in one table, with Contrave's label numbers and Wegovy and Zepbound beside them.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 20
- **Questions:** 8
- **Compounds:** 3

## The short answer

No randomized trial has tested low-dose naltrexone (LDN, about 1 to 4.5 mg a day) for weight loss. The weight data come from higher doses: naltrexone alone at 25 to 300 mg did not beat placebo in obesity trials, and Contrave, 32 mg of naltrexone with bupropion, took off 5.4% against 1.3% on placebo in a year. Wegovy's main trial reached 14.9%, Zepbound's 20.9%.

Every number checked at its primary source · Nov 20, 2026 · [20 sources](https://pepvault.app/guides/ldn-for-weight-loss#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** No randomized trial of low-dose naltrexone (1 to 4.5 mg) for weight; small controlled trials of naltrexone alone at 25 to 300 mg; phase 3 trials for Contrave, Wegovy and Zepbound.

## Does low-dose naltrexone cause weight loss?

Nobody has measured it in a trial. LDN is naltrexone, an opioid-blocking drug approved at 50 mg for alcohol and opioid dependence, taken at a tenth of that or less and prescribed off-label (pepvault.app/glossary/off-label), for a use the label does not cover[1](https://pepvault.app/guides/ldn-for-weight-loss#source-1). Its trials, in fibromyalgia, Crohn's disease, MS and long COVID, measured pain, fatigue and disease activity, not weight; our LDN guide (pepvault.app/guides/low-dose-naltrexone) sets those out.

The approved label mentions weight only in passing: increased appetite, weight loss and weight gain all appear among the events seen in fewer than 1% of people in its opioid-addiction trials[1](https://pepvault.app/guides/ldn-for-weight-loss#source-1). So the honest answer to "does LDN make you lose weight" is that every number below comes from a different dose. Here is which naltrexone is which:

| Form | Naltrexone a day | What it is |
| --- | --- | --- |
| Low-dose naltrexone (LDN) | About 1 to 4.5 mg | Off-label, usually made by a compounding pharmacy; no weight trial |
| Older "low-dose" trials | 25 mg | Half the approved tablet; tested in smokers and in people on antipsychotics[8](https://pepvault.app/guides/ldn-for-weight-loss#source-8) [11](https://pepvault.app/guides/ldn-for-weight-loss#source-11) |
| Contrave (with bupropion 360 mg) | 32 mg | FDA-approved to reduce excess weight and keep it off, in adults with obesity or overweight and a related condition[2](https://pepvault.app/guides/ldn-for-weight-loss#source-2) |
| Naltrexone tablets | 50 mg | FDA-approved for alcohol and opioid dependence[1](https://pepvault.app/guides/ldn-for-weight-loss#source-1) |
| 1980s obesity trials | 50 to 300 mg | Tested for weight loss; did not beat placebo[5](https://pepvault.app/guides/ldn-for-weight-loss#source-5) [6](https://pepvault.app/guides/ldn-for-weight-loss#source-6) [7](https://pepvault.app/guides/ldn-for-weight-loss#source-7) |

Watch the word "low" when you read about it. In the smoking papers, "low-dose naltrexone" means 25 mg, more than five times the LDN dose[13](https://pepvault.app/guides/ldn-for-weight-loss#source-13).

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Whatever you take, the scale is the measure the trials used. PepVault's weight log draws your trend week by week, so you can see your own line against these numbers and bring it to your prescriber.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What did trials of naltrexone on its own find for weight?

The idea is old: the body's own opioids help regulate eating, and in animals blocking them cuts food intake[5](https://pepvault.app/guides/ldn-for-weight-loss#source-5). In people, it mostly did not turn into weight loss. These are the trials; all but the 4-day feeding study were blinded and against placebo (pepvault.app/glossary/placebo):

| Trial | People, dose, length | Weight result |
| --- | --- | --- |
| Atkinson 1985[5](https://pepvault.app/guides/ldn-for-weight-loss#source-5) | 60 adults with obesity, 50 or 100 mg, 8 weeks | No significant loss against placebo; women alone lost 1.7 kg |
| Malcolm 1985[6](https://pepvault.app/guides/ldn-for-weight-loss#source-6) | 41 adults with obesity, 200 mg, 10 weeks | 1.8 kg on naltrexone vs 1.5 kg on placebo: no difference |
| Mitchell 1987[7](https://pepvault.app/guides/ldn-for-weight-loss#source-7) | Men with obesity on a diet, 300 mg, 8 weeks | No advantage over placebo |
| Spiegel 1987[19](https://pepvault.app/guides/ldn-for-weight-loss#source-19) | 17 men with obesity, 25 rising to 200 mg, 4 days | Lunch intake fell 30%; body weight did not change |
| Tek 2014 pilot[8](https://pepvault.app/guides/ldn-for-weight-loss#source-8) | 24 women with schizophrenia, 25 mg, 8 weeks | Lost 3.4 kg vs gained 1.4 kg on placebo |
| Yale, NCT01866098[9](https://pepvault.app/guides/ldn-for-weight-loss#source-9) | 144 adults on antipsychotics, 25 or 50 mg, 52 weeks | +0.7 kg (25 mg) and −1.0 kg (50 mg) vs −0.2 kg on placebo: no difference |

The longest and largest of them, the Yale year-long trial, found nothing on the scale[9](https://pepvault.app/guides/ldn-for-weight-loss#source-9), and a 2025 systematic review of the antipsychotic trials found that naltrexone did not separate from placebo on weight or BMI (pepvault.app/glossary/bmi)[10](https://pepvault.app/guides/ldn-for-weight-loss#source-10). The 8-week pilot that looked promising did not hold up at 52 weeks[8](https://pepvault.app/guides/ldn-for-weight-loss#source-8) [9](https://pepvault.app/guides/ldn-for-weight-loss#source-9).

One small open study is often quoted: 10 women with PCOS took 50 mg for 6 months and their BMI fell from 29.9 to 26.1[18](https://pepvault.app/guides/ldn-for-weight-loss#source-18). With no placebo group, it cannot say how much of that was the drug. The high-dose trials also saw liver enzymes rise in a few people, at 50 to 300 mg[5](https://pepvault.app/guides/ldn-for-weight-loss#source-5) [6](https://pepvault.app/guides/ldn-for-weight-loss#source-6) [7](https://pepvault.app/guides/ldn-for-weight-loss#source-7).

## Does naltrexone stop weight gain when you quit smoking?

A little, and this is where the low-milligram data are strongest. In a 400-person Yale trial, smokers who quit on 25 mg plus a nicotine patch gained 0.7 kg in 6 weeks, against 1.9 kg on placebo[11](https://pepvault.app/guides/ldn-for-weight-loss#source-11). Pooling the two largest trials (25 to 100 mg), women on naltrexone gained 3.3 kg by 6 months against 5.5 kg on placebo; men saw no difference[12](https://pepvault.app/guides/ldn-for-weight-loss#source-12). In a 27-week trial in smokers worried about weight, the gap (6.8 lb vs 9.7 lb) was not significant[13](https://pepvault.app/guides/ldn-for-weight-loss#source-13).

So naltrexone at 25 to 100 mg slowed weight gain after quitting, by a kilogram or two. None of these trials tested 4.5 mg, and none tested weight loss in people trying to lose weight.

## With this guide

### Low-Dose Naltrexone

- [Low-Dose Naltrexone: the full reference](https://pepvault.app/peptides/low-dose-naltrexone)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Boxed warning](https://pepvault.app/glossary/boxed-warning)
- [Open-label](https://pepvault.app/glossary/open-label)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

## Why does naltrexone work with bupropion?

The pair was designed to work on two parts of the brain at once. Bupropion, an antidepressant, activates POMC neurons, the cells in the hypothalamus that signal fullness; naltrexone blocks the opioid signals that push back against that fullness and against weight loss[14](https://pepvault.app/guides/ldn-for-weight-loss#source-14). The Contrave label adds what the lab work showed: together they raised POMC firing in cells and cut food intake when given into the brain's reward area in mice[2](https://pepvault.app/guides/ldn-for-weight-loss#source-2).

The dose-finding trial bore it out in people. In 419 adults over 24 weeks, each naltrexone-plus-bupropion arm, at 16, 32 or 48 mg of naltrexone, beat placebo by 3.5 to 4.7 percentage points of body weight and beat naltrexone alone[14](https://pepvault.app/guides/ldn-for-weight-loss#source-14). The phase 3 trials, COR-I among them, then used 32 mg, the dose on the label[2](https://pepvault.app/guides/ldn-for-weight-loss#source-2).

## How much weight does Contrave take off?

About 4% to 8% of body weight in a year, in the three 56-week trials the label tables, against 1.3% to 4.9% on placebo[2](https://pepvault.app/guides/ldn-for-weight-loss#source-2). The label's numbers, with diet and exercise counselling in every arm:

| Contrave trial (56 weeks) | Weight change, Contrave vs placebo | Lost 5% or more | Lost 10% or more |
| --- | --- | --- | --- |
| COR-I | −5.4% vs −1.3% | 42% vs 17% | 21% vs 7% |
| COR-BMOD (intensive behaviour program) | −8.1% vs −4.9% | 57% vs 43% | 35% vs 21% |
| COR-Diabetes (type 2 diabetes) | −3.7% vs −1.7% | 36% vs 18% | 15% vs 5% |

The label builds in a check: if someone has not lost at least 5% after 12 weeks on the full dose, it says to stop, because meaningful loss is unlikely to follow[2](https://pepvault.app/guides/ldn-for-weight-loss#source-2). Nausea was the most common side effect, 32.5% against 6.7% on placebo, followed by constipation and headache[2](https://pepvault.app/guides/ldn-for-weight-loss#source-2). Because bupropion is also an antidepressant, the label carries a boxed warning (pepvault.app/glossary/boxed-warning) about suicidal thoughts in young people[2](https://pepvault.app/guides/ldn-for-weight-loss#source-2).

## How does that compare with Wegovy and Zepbound?

Wegovy's trial took off about three times Contrave's, Zepbound's about four times, counted raw or minus placebo (Contrave 4.1 points over placebo, Wegovy 12.4, Zepbound 17.8). These are each drug's main obesity trial as its own label reports it: different trials, lengths, people and years, not a head-to-head test.

| Drug, trial | Length | Weight change, drug vs placebo | Lost 5% or more | Lost 10% or more |
| --- | --- | --- | --- | --- |
| LDN, 1 to 4.5 mg | No trial | Not measured | Not measured | Not measured |
| Contrave, COR-I[2](https://pepvault.app/guides/ldn-for-weight-loss#source-2) | 56 weeks | −5.4% vs −1.3% | 42% vs 17% | 21% vs 7% |
| Wegovy 2.4 mg, STEP 1[3](https://pepvault.app/guides/ldn-for-weight-loss#source-3) [15](https://pepvault.app/guides/ldn-for-weight-loss#source-15) | 68 weeks | −14.9% vs −2.4% | 83.5% vs 31.1% | 66.1% vs 12.0% |
| Zepbound 15 mg, SURMOUNT-1[4](https://pepvault.app/guides/ldn-for-weight-loss#source-4) [16](https://pepvault.app/guides/ldn-for-weight-loss#source-16) | 72 weeks | −20.9% vs −3.1% | 90.9% vs 34.5% | 83.5% vs 18.8% |

<!--promo-->

Whatever you take, the scale is the measure the trials used. PepVault's weight log draws your trend week by week, so you can see your own line against these numbers and bring it to your prescriber. [Track your weight in PepVault](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-ldn-for-weight-loss-inline&mt=8)

<!--/promo-->

Wegovy is semaglutide (pepvault.app/peptides/semaglutide) and Zepbound is tirzepatide (pepvault.app/peptides/tirzepatide); the two labels sit side by side at pepvault.app/drugs/compare/wegovy-vs-zepbound.

## Is anyone testing LDN for weight now?

One registered trial includes it. AgelessRx, a telehealth longevity company, is randomizing 150 of its own patients who lost at least 15 lb on a GLP-1 to four ways of stopping it: metformin, metformin with rapamycin, metformin with LDN, or vitamin C as the control, with weight reported by the patients every 4 weeks[20](https://pepvault.app/guides/ldn-for-weight-loss#source-20).

Two details matter. Its LDN arm climbs from 1.5 mg twice a day to 4.5 mg twice a day, 9 mg a day, twice the usual LDN dose. And it is open-label (pepvault.app/glossary/open-label): everyone knows what they take. The record still reads "recruiting", with its main results due in August 2025 and no update since July 2025; no results are posted[20](https://pepvault.app/guides/ldn-for-weight-loss#source-20).

That makes it the only registered trial we found with an LDN arm and a weight outcome, and it asks a narrower question: whether LDN with metformin slows the regain after stopping a GLP-1, not whether LDN takes weight off. Our guide on keeping weight off after a GLP-1 (pepvault.app/guides/keeping-weight-off-after-a-glp-1) has what the stopping trials found.

## Can you take LDN with a GLP-1 or Contrave?

Neither the Wegovy nor the Zepbound label names naltrexone; both note that they slow stomach emptying, which can change how other tablets are absorbed[3](https://pepvault.app/guides/ldn-for-weight-loss#source-3) [4](https://pepvault.app/guides/ldn-for-weight-loss#source-4). The AgelessRx trial gives LDN beside a tapering semaglutide dose[20](https://pepvault.app/guides/ldn-for-weight-loss#source-20). Contrave is different: its label says taking it with other naltrexone products is not recommended, so LDN on top of Contrave doubles up the same drug[2](https://pepvault.app/guides/ldn-for-weight-loss#source-2).

The rule that matters most is the opioid one. Naltrexone in any dose blocks opioid painkillers and can bring on withdrawal in someone taking methadone or buprenorphine; the labels of both naltrexone and Contrave rule those combinations out[1](https://pepvault.app/guides/ldn-for-weight-loss#source-1) [2](https://pepvault.app/guides/ldn-for-weight-loss#source-2). In 2026, doctors in Arizona reported a man on methadone who went into severe withdrawal after his first dose of a naltrexone weight-loss kit bought through an online telehealth service[17](https://pepvault.app/guides/ldn-for-weight-loss#source-17).

<!--promo-->

PepVault logs a daily tablet with a reminder at the time you set, so each dose sits in one history beside your weight. [Set reminders in PepVault](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-ldn-for-weight-loss-inline&mt=8)

<!--/promo-->

**Commonly reported:** some people on LDN describe fewer cravings and less evening snacking, others notice no change on the scale, and vivid dreams in the first weeks are the side effect mentioned most.

**When to get help** Anyone taking naltrexone at any dose who needs pain relief for surgery, dental work or an injury should tell the treating clinician first, because opioid painkillers will not work as expected[1](https://pepvault.app/guides/ldn-for-weight-loss#source-1).

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Naltrexone hydrochloride tablets USP 50 mg, prescribing information (RemedyRepack). DailyMed, SPL version 10, effective November 11, 2026 (published November 16): Indications and usage; Contraindications; Adverse reactions. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f821dd49-3fa7-4d33-99de-19023ff1ae65)
2. Contrave (naltrexone HCl and bupropion HCl) extended-release tablets, prescribing information. Nalpropion Pharmaceuticals. DailyMed, SPL version 27, Nov 2025: sections 1, 2, 4, 6.1, 12.1, 12.2, 14. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=485ff360-32c8-11df-928b-0002a5d5c51b)
3. Wegovy (semaglutide) injection, prescribing information, section 14.2, Table 8 (Study 2, STEP 1). Novo Nordisk. DailyMed, SPL version 19, Jun 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
4. Zepbound (tirzepatide) injection, prescribing information, section 14 (Study 1, SURMOUNT-1). Eli Lilly. DailyMed, SPL version 40, Sep 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
5. Atkinson RL et al. Effects of long-term therapy with naltrexone on body weight in obesity. Clin Pharmacol Ther. 1985. [PubMed 4042525](https://pubmed.ncbi.nlm.nih.gov/4042525/)
6. Malcolm R et al. A controlled trial of naltrexone in obese humans. Int J Obes. 1985. [PubMed 3908352](https://pubmed.ncbi.nlm.nih.gov/3908352/)
7. Mitchell JE et al. High-dose naltrexone therapy and dietary counseling for obesity. Biol Psychiatry. 1987. [PubMed 3790639](https://pubmed.ncbi.nlm.nih.gov/3790639/)
8. Tek C et al. A randomized, double-blind, placebo-controlled pilot study of naltrexone to counteract antipsychotic-associated weight gain: proof of concept. J Clin Psychopharmacol. 2014. [PubMed 25102328](https://pubmed.ncbi.nlm.nih.gov/25102328/)
9. ClinicalTrials.gov NCT01866098. Naltrexone for antipsychotic-induced weight gain (Yale University), posted results, accessed November 20, 2026. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01866098)
10. Lee K et al. Centrally-acting opioid receptor antagonists as a treatment for antipsychotic-induced weight gain: a systematic review and meta-analysis of clinical trial data. J Psychopharmacol. 2025. [PubMed 40406979](https://pubmed.ncbi.nlm.nih.gov/40406979/)
11. O'Malley SS et al. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Arch Intern Med. 2006. [PubMed 16567607](https://pubmed.ncbi.nlm.nih.gov/16567607/)
12. King AC et al. Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial. Biol Psychiatry. 2013. [PubMed 23177384](https://pubmed.ncbi.nlm.nih.gov/23177384/)
13. Toll BA et al. Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial. Drug Alcohol Depend. 2010. [PubMed 20542391](https://pubmed.ncbi.nlm.nih.gov/20542391/)
14. Greenway FL et al. Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo. J Clin Endocrinol Metab. 2009. [PubMed 19846734](https://pubmed.ncbi.nlm.nih.gov/19846734/)
15. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021. [PubMed 33567185](https://pubmed.ncbi.nlm.nih.gov/33567185/)
16. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022. [PubMed 35658024](https://pubmed.ncbi.nlm.nih.gov/35658024/)
17. Summers PJ et al. Probable naltrexone-precipitated opioid withdrawal in a patient receiving methadone maintenance after use of a weight-loss medication obtained through a direct-to-consumer telemedicine platform: a case report. Subst Abuse Treat Prev Policy. 2026. [PubMed 42989360](https://pubmed.ncbi.nlm.nih.gov/42989360/)
18. Fruzzetti F et al. Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome. Fertil Steril. 2002. [PubMed 12009347](https://pubmed.ncbi.nlm.nih.gov/12009347/)
19. Spiegel TA et al. Effect of naltrexone on food intake, hunger, and satiety in obese men. Physiol Behav. 1987. [PubMed 3628520](https://pubmed.ncbi.nlm.nih.gov/3628520/)
20. ClinicalTrials.gov NCT07092618. Effectiveness of alternative therapies in maintaining weight loss achieved by GLP-1 medications post-cessation (AgelessRx), accessed November 20, 2026. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07092618)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)

GLP-1s for PCOS: weight, periods, testosterone and pregnancy rates in the randomized trials, against metformin, plus what the labels say about pregnancy.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Low-Dose Naltrexone Studied range: 1–6 mg](https://pepvault.app/peptides/low-dose-naltrexone)
- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)

## Related guides

- Guide · The science

  ### [Low-dose naltrexone (LDN): what it's used for and what the trials show](https://pepvault.app/guides/low-dose-naltrexone)

  What low-dose naltrexone (LDN) is used for: every randomized trial by condition with its result against placebo, the long COVID trials and the opioid rule.

  Read the guide
- Guide · GLP-1s

  ### [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)

  What each trial tested for keeping weight off after a GLP-1: staying on, a lower dose, switching to a pill and exercise, with every result in one by-drug table.

  Read the guide
- Guide · GLP-1s

  ### [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)

  What happened to weight when semaglutide and tirzepatide were stopped in STEP 1, STEP 4 and SURMOUNT-4: how much came back, how fast, and what the labels say.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Low-Dose Naltrexone

- [Low-Dose Naltrexone: the full reference](https://pepvault.app/peptides/low-dose-naltrexone)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Boxed warning](https://pepvault.app/glossary/boxed-warning)
- [Open-label](https://pepvault.app/glossary/open-label)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
